A potential antibody treatment for COVID-19 from Singapore's DSO National Laboratories might be just a few months away from human trials. The country's largest defence R&D organisation said it has discovered five antibodies that could potentially neutralise the virus that causes COVID-19. Harvested from recovered patients, the antibodies act by binding and covering the part of the virus that enables it to enter the cells.
Subscribe to our channel here:
Subscribe to our news service on Telegram:
Follow us:
CNA:
CNA Lifestyle:
Facebook:
Instagram:
Twitter:
CNA,Channel NewsAsia,COVID-19,antibody treatment,DSO National Laboratories,human trials,research phase,clinical phase,supply,manufacturing,DSO,Singapore,National University of Singapore,NUS,Yong Loo Lin School of Medicine,Life Sciences Institute,
0 Comments